Tai Sandi See, Chief Development Officer: Lexeo Therapeutics LXEO Planned sale · Filed 02/18

Trade details

Type: Planned sale notice
Stock: Lexeo Therapeutics LXEO
Person: Tai Sandi SeeChief Development Officer
Planned sale date: 26/02/18
Filed: 26/02/18

More to sell after $3,580 in 3 months

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Tai Sandi See's recent trades

Tai Sandi SeeChief Development Officer
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$3,578
386 sh
$3,578
Filed 25/11/20
Traded 25/11/18
Tai Sandi SeeChief Development Officer
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$3,580
386 sh
$3,580
Filed 25/11/18
Traded 25/11/18
Tai Sandi SeeChief Development Officer
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$34.4K
3,844 sh
$34.4K
Filed 25/10/17
Traded 25/10/17
Tai Sandi SeeChief Development Officer
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$421
44 sh
$421
Filed 25/10/17
Traded 25/10/17
Tai Sandi SeeChief Development Officer
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$34.8K
3,888 sh
$34.8K
Filed 25/10/17
Traded 25/10/17